Giving Science a Voice, Giving Patients Hope!

This October, Azur Health Science will be attending one of the most important events in the rare disease ecosystem:

World Orphan Drug Congress – Amsterdam
October 28–29 | Hall 10 – Stand S20

The World Orphan Drug Congress is a unique platform bringing together pharmaceutical companies, biotechs, CROs, patient associations, and regulators, all driven by a common mission: to accelerate the development and accessibility of treatments for rare diseases.

For us at Azur Health Science, this event is much more than a conference—it’s an opportunity to:

  • Share our expertise in Regulatory Medical Writing & Consulting

  • Showcase how we help transform complex science into clear, regulatory-ready documentation

  • Engage with partners who share our commitment to patients living with rare diseases

We look forward to connecting with healthcare innovators, exchanging ideas, and building collaborations that will make a lasting impact on the rare disease community.